Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q89537195 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000215.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q89537195 | ||
| 024 | ‡a 0000-0003-2159-2730 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q89537195 | ||
| 100 | 0 | ‡a Yaonan Wang ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Yaonan Wang ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's 13-[CH2CO-Cys-(Bzl)-OBzl]-Berberine: Exploring The Correlation Of Anti-Tumor Efficacy With ROS And Apoptosis Protein | ||
| 670 | ‡a Author's Development of 13-Cys-BBR as an Agent Having Dual Action of Anti-Thrombosis and Anti-Inflammation | ||
| 670 | ‡a Author's Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine | ||
| 670 | ‡a Author's Simultaneous Quantification of γ-Hydroxybutyrate, γ-Butyrolactone, and 1,4-Butanediol in Four Kinds of Beverages | ||
| 909 | ‡a (orcid) 0000000321592730 ‡9 1 | ||
| 919 | ‡a simultaneousquantificationofγhydroxybutyrateγbutyrolactoneand14butanediolin4kindsofbeverages ‡A Simultaneous Quantification of γ-Hydroxybutyrate, γ-Butyrolactone, and 1,4-Butanediol in Four Kinds of Beverages ‡9 1 | ||
| 919 | ‡a modifyingiccawithtrpphephetoenhanceinvivoactivityandformnanomedicine ‡A Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine ‡9 1 | ||
| 919 | ‡a developmentof13cysbbrasanagenthavingdualactionofantithrombosisandantiinflammation ‡A Development of 13-Cys-BBR as an Agent Having Dual Action of Anti-Thrombosis and Anti-Inflammation ‡9 1 | ||
| 919 | ‡a 13berberineexploringthecorrelationofantitumorefficacywithrosandapoptosisprotein ‡A 13-[CH2CO-Cys-(Bzl)-OBzl]-Berberine: Exploring The Correlation Of Anti-Tumor Efficacy With ROS And Apoptosis Protein ‡9 1 | ||
| 996 | ‡2 NTA|182825310 | ||
| 996 | ‡2 NTA|071984771 | ||
| 996 | ‡2 SUDOC|229207154 | ||
| 996 | ‡2 PLWABN|9811552474005606 | ||
| 996 | ‡2 LC|n 83156655 | ||
| 996 | ‡2 ISNI|0000000419504938 | ||
| 996 | ‡2 LC|nb2014029211 | ||
| 996 | ‡2 CAOONL|ncf11884146 | ||
| 996 | ‡2 NTA|33770208X | ||
| 996 | ‡2 NSK|000158613 | ||
| 996 | ‡2 PLWABN|9811769723105606 | ||
| 996 | ‡2 KRNLK|KAC200109062 | ||
| 996 | ‡2 NSK|000736560 | ||
| 996 | ‡2 NTA|340415975 | ||
| 996 | ‡2 PLWABN|9811772643705606 | ||
| 996 | ‡2 SUDOC|197649793 | ||
| 996 | ‡2 CAOONL|ncf10389396 | ||
| 996 | ‡2 LC|n 81137175 | ||
| 996 | ‡2 LC|n 99042213 | ||
| 996 | ‡2 NTA|202760235 | ||
| 996 | ‡2 NTA|369417666 | ||
| 996 | ‡2 NTA|401474194 | ||
| 996 | ‡2 ISNI|0000000393615735 | ||
| 996 | ‡2 ISNI|0000000395756013 | ||
| 996 | ‡2 NII|DA09949269 | ||
| 996 | ‡2 PLWABN|9811771554805606 | ||
| 996 | ‡2 BIBSYS|90191049 | ||
| 996 | ‡2 NTA|304118869 | ||
| 996 | ‡2 BIBSYS|2075601 | ||
| 996 | ‡2 PLWABN|9811357029705606 | ||
| 996 | ‡2 J9U|987007355317705171 | ||
| 996 | ‡2 NTA|364154853 | ||
| 996 | ‡2 BNF|14460012 | ||
| 996 | ‡2 NSK|000708014 | ||
| 996 | ‡2 BIBSYS|15029296 | ||
| 996 | ‡2 NTA|438699432 | ||
| 996 | ‡2 NSK|000648337 | ||
| 996 | ‡2 LC|n 84020942 | ||
| 996 | ‡2 LC|n 96061111 | ||
| 996 | ‡2 ISNI|0000000084849044 | ||
| 996 | ‡2 PLWABN|9811772648405606 | ||
| 996 | ‡2 NSK|000593724 | ||
| 996 | ‡2 NTA|439922674 | ||
| 996 | ‡2 DNB|1339954060 | ||
| 996 | ‡2 NTA|34471215X | ||
| 996 | ‡2 PLWABN|9810673005305606 | ||
| 996 | ‡2 NSK|000431915 | ||
| 996 | ‡2 NSK|000461453 | ||
| 996 | ‡2 NTA|387585427 | ||
| 996 | ‡2 NSK|000679496 | ||
| 996 | ‡2 NSK|000565897 | ||
| 996 | ‡2 DNB|1232186325 | ||
| 996 | ‡2 PLWABN|9811566399305606 | ||
| 996 | ‡2 NSK|000727709 | ||
| 996 | ‡2 NTA|121186539 | ||
| 996 | ‡2 LC|no2022103974 | ||
| 996 | ‡2 CAOONL|ncf10197331 | ||
| 996 | ‡2 ISNI|000000003941368X | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
